[HTML][HTML] Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial

B Coulibaly, A Zoungrana, FP Mockenhaupt… - PLoS one, 2009 - journals.plos.org
Background With the availability of new preventive and curative interventions, global malaria
control has been strengthened significantly in recent years. Drugs effective in reducing …

[HTML][HTML] Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from …

A Zoungrana, B Coulibaly, A Sié, I Walter-Sack… - PLoS …, 2008 - journals.plos.org
Background Besides existing artemisinin-based combination therapies, alternative safe,
effective and affordable drug combinations against falciparum malaria are needed. Methylene …

Efficacy of methylene blue monotherapy in semi‐immune adults with uncomplicated falciparum malaria: a controlled trial in Burkina Faso

M Bountogo, A Zoungrana, B Coulibaly… - Tropical Medicine & …, 2010 - Wiley Online Library
Objective To assess the efficacy of methylene blue (MB) monotherapy in semi‐immune adults
with uncomplicated malaria in Burkina Faso. Methods In an open‐label controlled phase II …

[HTML][HTML] Rapid identification of genes controlling virulence and immunity in malaria parasites

…, J Gitaka, J Tang, K Yahata, A Zoungrana… - PLoS …, 2017 - journals.plos.org
Identifying the genetic determinants of phenotypes that impact disease severity is of
fundamental importance for the design of new interventions against malaria. Here we present a …

[HTML][HTML] Within-host Competition Does Not Select for Virulence in Malaria Parasites; Studies with Plasmodium yoelii

…, J Tang, N Kobayashi, M Inoue, A Zoungrana… - PLoS …, 2015 - journals.plos.org
In endemic areas with high transmission intensities, malaria infections are very often composed
of multiple genetically distinct strains of malaria parasites. It has been hypothesised that …

[HTML][HTML] Factors associated with the low immunization coverage in the second year of life in the central region of Burkina Faso

…, AK AHAWO, H TALL, KA ZOUNGRANA - Fortune Journal of …, 2022 - fortuneonline.org
Introduction: The second year of life immunization is the administration of vaccines to a child
between 12 and 24 months of age. After seven years of implementation of this immunization…

How to implement medical and patient associations in low‐income countries: A proposition from the African French Alliance for the Treatment of Haemophilia (AFATH)

…, EB Zein, A Zohoun, A Zongo, A Zoungrana - …, 2021 - Wiley Online Library
Introduction There is a lack of joint recommendations by healthcare professionals (HCP) and
patient organizations when a partnership between high and low‐income countries in the …

Quantitative Seq-LGS–Genome-Wide Identification of Genetic Drivers of Multiple Phenotypes in Malaria Parasites

…, J Gitaka, J Tang, K Yahata, A Zoungrana… - bioRxiv, 2016 - biorxiv.org
Identifying the genetic determinants of phenotypes that impact on disease severity is of
fundamental importance for the design of new interventions against malaria. Traditionally, such …

[PDF][PDF] Impact assessment of childhood immunization programs in limited-resource settings: challenges in ascertaining vaccination status and application to …

L KABORE - access.archive-ouverte.unige.ch
Background Following the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13)
in Burkina Faso in 2013, we undertook a series of studies aimed at documenting …

Covid-19 Health crisis and cross-border trade in West Africa

TD Zoungrana, O Combelem… - Journal of African Trade, 2023 - jat.afreximbank.com
The Economic Community of West African States (ECOWAS) Strict has adopted strict restrictions
since the appearance of the new coronavirus disease in 2019 (Covid-19). This article …